about
Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD.Altered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease.Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cellsEffector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.Peptide/MHC tetramer-based sorting of CD8⁺ T cells to a leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire.Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt.B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathwaysPhase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients.CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host diseaseIn vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestationsThe biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting.Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome.T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD.Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease.Effectiveness of an algorithm-based approach to the utilization of plerixafor in patients undergoing chemotherapy-based stem cell mobilization.A critical role for donor-derived IL-22 in cutaneous chronic GVHD.Chemokines and graft-versus-host diseaseImpaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHDIdentification of Cosalane as an Inhibitor of Human and Murine CC-Chemokine Receptor 7 Signaling via a High-Throughput ScreenR707, a fully human antibody directed against CC-chemokine receptor 7, attenuates xenogeneic acute graft-versus-host disease
P50
Q30573584-66598110-809B-4081-8D65-0972553153EEQ33851696-3BDBD2B5-F92A-498A-AE2A-1E9FD8354A7BQ33931876-0584FCFC-785C-419A-9AC9-EC25AF0BE779Q34754302-47521CB9-9107-42DF-8911-52DBFE37C0E5Q35152121-895ABA50-A8B7-4B08-B5B3-BFEA2C624012Q36139724-4B86F325-3325-42D0-8007-168F85BA5C68Q36250962-EC2C740F-CB19-4E23-B67D-07A330966615Q36264692-A423AC4D-FE92-4959-9639-72D618A69871Q37065718-EBD2506B-3C4B-4571-9B62-6B7A196E87CEQ37086953-34ECED76-2493-4B28-8499-B3D515F23CFBQ37228646-07DD1DB7-4D3F-4189-8022-C4F6B044CC22Q38978799-198B46D8-F967-43A7-857E-B37214A671D9Q40183485-2643B496-B3A2-40AE-995E-1C362716F085Q41896478-22F6539F-0397-47A2-BC05-837C59D9E4FDQ45343077-1C36BD21-C7AD-40B4-A829-4979D3A6035CQ47935463-4A908C6F-161A-4A35-90AC-A43723C5A06EQ55014764-A99F90B0-F4D2-4893-AE8B-D68437CFA625Q58723868-F2092246-1108-46CC-84BC-FD822FA27B0AQ59357904-20B62FBD-CAE9-4130-99CC-926EB1E05A99Q91480636-4CAF994B-7F52-4305-8A64-C86B144C6B77
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
James M Coghill
@ast
James M Coghill
@en
James M Coghill
@es
James M Coghill
@nl
type
label
James M Coghill
@ast
James M Coghill
@en
James M Coghill
@es
James M Coghill
@nl
prefLabel
James M Coghill
@ast
James M Coghill
@en
James M Coghill
@es
James M Coghill
@nl
P106
P21
P31
P496
0000-0002-4736-0877